| Cell-penetrating peptides: classes, origin, and current landscape
| [0002]
|
| Introduction of exogenous antigens into the MHC class 1 processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo
| [0016]
|
| Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex
| [0016]
[0119]
|
| Use of cell permeable NBD peptides for suppression of inflammation
| [0016]
[0119]
|
| Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein
| [0016]
|
| Nucleic Acid Hybridisation
| [0021]
|
| J Mol Biol
| [0041]
|
| Nature Biotechnology
| [0046]
|
| Fusion protein linkers: property, design and functionality
| [0051]
|
| Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology
| [0056]
|
| Molecular Cloning: A Laboratory Manual
| [0063]
|
| Current Protocols in Molecular Biology
| [0063]
|
| Affinity Chromatography: Methods and Protocols
| [0071]
|
| Phosphoinositide-dependent kinase 1 integrates T cell receptor and CD28 co-receptor signaling to effect NF-κB induction and T cell activation
| [0124]
|
| Toll-Like Receptor Expression and Activation in Mice with Experimental Dry Eye
| [0140]
|
| Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt Signaling
| [0153]
|
| VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist
| [0169]
|
| Characterization of an MPS 1-K knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation
| [0207]
|
| Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
| [0215]
|
| Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
| [0223]
|
| Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants
| [0236]
|
| Unified Huntington's Disease Rating Scale: Reliability and Consistency
| [0252]
|
| Cell-penetrating peptides: Application in vaccine delivery
| [0254]
|
| TAP-independent presentation of CTL epitopes by Trojan antigens
| [0254]
|
| Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide
| [0254]
|
| Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses
| [0254]
|
| Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma
| [0254]
|
| Human cytomegalovirus protein pp65: an efficient protein carrier system into human dendritic cells
| [0254]
|
| Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells
| [0254]
|
| Regulation of antigen presentation by Mycobacterim tuberculosis: a roll for Toll-like receptors
| [0255]
|
| Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo
| [0255]
|
| The Tuberculosis Vaccines Pipeline
| [0255]
|
| Expert Rev Vaccines
| [0255]
|
| Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
| [0257]
|
| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
| [0258]
|
| A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
| [0268]
|